Documents
Application Sponsors
Marketing Status
Application Products
| 001 | POWDER FOR ORAL SOLUTION | 1.5MG | 0 | EVRYSDI | RISDIPLAM | 
FDA Submissions
| TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2020-08-07 | PRIORITY  | 
| EFFICACY; Efficacy | SUPPL | 3 | AP | 2022-05-27 | STANDARD  | 
| EFFICACY; Efficacy | SUPPL | 5 | AP | 2022-05-27 | PRIORITY  | 
| LABELING; Labeling | SUPPL | 6 | TA | 2022-03-21 | STANDARD  | 
Submissions Property Types
| ORIG | 1 | Null | 10 | 
| SUPPL | 3 | Null | 7 | 
| SUPPL | 5 | Null | 15 | 
| SUPPL | 6 | Null | 15 | 
CDER Filings
GENENTECH INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213535
            [companyName] => GENENTECH INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EVRYSDI","activeIngredients":"RISDIPLAM","strength":"1.5MG","dosageForm":"POWDER FOR ORAL SOLUTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"08\/07\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213535s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"08\/07\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213535s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/213535Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2020-08-07
        )
)